NCT01186627

Brief Summary

A specified version of the Apgar-Score, that can be used in newborns under resuscitation, was developed and its value to predict chronic damage in preterm infants will be tested.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 20, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 23, 2010

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

October 14, 2010

Status Verified

October 1, 2010

Enrollment Period

2 years

First QC Date

August 20, 2010

Last Update Submit

October 13, 2010

Conditions

Premature BirthMortalityApgar Score

Keywords

Neurodevelopmental ImpairmentIntraventricular hemorrhageRetinopathy of prematurityMortalityApgar Score

Eligibility Criteria

Age2 Years - 2 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Former preterm infants with a gestational age below 32 weeks which have been included in the TEST-APGAR Study are now screened at a corrected age of 2 years after birth.

You may qualify if:

  • All preterm infants included in the TEST-APGAR Study

You may not qualify if:

  • Missing parental Consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Carl Gustav Carus

Dresden, Dresden, 01307, Germany

RECRUITING

MeSH Terms

Conditions

Premature BirthRetinopathy of Prematurity

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesRetinal DiseasesEye DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Mario Ruediger

    Technische Universität Dresden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 20, 2010

First Posted

August 23, 2010

Study Start

April 1, 2010

Primary Completion

April 1, 2012

Study Completion

December 1, 2012

Last Updated

October 14, 2010

Record last verified: 2010-10

Locations

DE(1)